title: Mycobacterium chelonae infection in a patient being treated with adalimumab.
authors.forename: R
authors.initials: R
authors.lastname: Conejero
authors.forename: M
authors.initials: M
authors.lastname: Ara
authors.forename: M
authors.initials: M
authors.lastname: Lorda
authors.forename: I
authors.initials: I
authors.lastname: Rivera
mesh_terms: D000068879:Adalimumab; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D001799:Blood Sedimentation; D002111:Calcaneus / Q000382:microbiology / Q000473:pathology; D017577:Cutaneous Fistula / Q000209:etiology / Q000382:microbiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005260:Female; D005533:Foot Dermatoses / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008682:Metatarsal Bones / Q000382:microbiology / Q000473:pathology; D009165:Mycobacterium Infections, Nontuberculous / Q000209:etiology* / Q000382:microbiology; D016926:Mycobacterium chelonae / Q000302:isolation & purification*; D010019:Osteomyelitis / Q000209:etiology / Q000382:microbiology
chemical_list: D000305:Adrenal Cortex Hormones; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D000068879:Adalimumab